Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.Anand A Patel,Kirk Cahill,Angella Charnot-Katsikas,Hongtao Liu,Sandeep Gurbuxani,Michael Thirman,Satyajit Kosuri,Andrew S Artz,Richard A Larson,Wendy Stock,Jeremy Segal,Olatoyosi OdenikeBRITISH JOURNAL OF HAEMATOLOGY(2020)引用 29|浏览37暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要